Initiation of eAArly DETECT 2 - U.S. Clinical Study to Evaluate Performance of Next Generation Test on Advanced Adenomas over ...

Biomed Industries to Advance NA-931 Into Two Global Phase 3 Trials as Monotherapy and in Combination With Semaglutide and Tirzepatide for Obesity Advancing NA-931 into two Phase 3 programs as ...

Mainz Biomed (MYNZ) reviewed its major accomplishments for the year ended December 31, 2025. “I’m extremely pleased with the achievements of our ...

The significant stock decline suggests investors may have concerns about the substantial investment and its long-term impact on Ping An’s financial position, despite the company’s assertion that the ...

HONG KONG, Jan. 09, 2026 (GLOBE NEWSWIRE) -- Ping An Biomedical Co., Ltd (NASDAQ: PASW) (hereinafter referred to as “Ping An Bio”) announced that it has entered into a non-binding memorandum (the ...

We are at an inflection point in how we support science in the U.S. New York state must invest in its science institutions and workforce.

Logan Jenner, a five-year-old battling acute myeloid leukemia, found new hope through a clinical trial that used Functional Precision Medicine to guide a personalized treatment approach after standard ...

Marion Underwood resigned after two years as provost and executive vice president at Colorado State University's main campus ...

Ping An Biomedical Co., Ltd (NASDAQ: PASW) (hereinafter referred to as "Ping An Bio") announced that it has entered into a non-binding memorandum (the "Investment ...

Researchers have developed a compact handheld imaging probe that could expand the clinical and research use of photoacoustic ...

Pursuant to the Agreement, the acquisition is expected to be completed within 90 calendar days subject to due diligence and a ...

Clearside Biomedical ( ($CLSDQ) ) just unveiled an announcement. Clearside Biomedical, Inc., which filed for Chapter 11 bankruptcy protection in ...